BioStock: Iconovo’s collaboration with Stevanato marches on

Since entering a collaboration with the Italian healthcare technology company Stevanato Group, Iconovo has taken significant steps towards commercialisation with its ICOcap inhaler platform. After receiving CE-marking for use in clinical trials earlier this year, most recently the device has been submitted to the FDA by Stevanato as Type III Drug Master File, a certification that would guarantee the device a stronger standing globally, especially on the US market.

Read the full article at biostock.se:

https://www.biostock.se/en/iconovos-collaboration-with-stevanato-marches-on/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se